| 06/05/2026 3:16 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/03/2026 8:28 AM | Psyence Biomedical (1985062) Subject Psyence Labs Ltd (2133217) Filed by | Form SCHEDULE 13D | |
| 04/23/2026 3:15 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/20/2026 7:25 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/17/2026 3:59 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/02/2026 6:07 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/20/2026 4:25 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/19/2026 10:19 AM | Psyence Biomedical (1985062) Subject Weiner Jeffrey David (2111558) Filed by | Form SCHEDULE 13G | |
| 02/19/2026 6:19 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/13/2026 3:01 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 02/12/2026 7:40 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
The tiny chipmaker set to supply Musk 5 billion chips (Ad) SpaceX and xAI just completed a $1.25 trillion merger - and Musk may no longer need data centers from Microsoft, Amazon, or Google.
Tech expert and angel investor Jeff Brown has identified one chipmaker, 148 times smaller than NVIDIA, that is set to supply Musk with 5 billion chips over the next two years. Brown brings decades of senior executive experience at Qualcomm, Juniper Networks, and NXP Semiconductors to this call. Watch Jeff Brown's urgent briefing before it comes down |
| 01/29/2026 5:10 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/27/2026 5:03 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/14/2026 3:30 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/13/2026 5:17 PM | Kaos Capital Ltd (2100448) Filed by Psyence Biomedical (1985062) Subject | Form SCHEDULE 13D/A | |
| 01/13/2026 6:58 AM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 7:53 PM | Psyence Biomedical (1985062) Filer | Form 6-K/A | |
| 01/08/2026 3:06 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/10/2025 5:09 PM | Kaos Capital Ltd (2100448) Filed by Psyence Biomedical (1985062) Subject | Form SCHEDULE 13D | |
| 11/21/2025 4:18 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/20/2025 4:23 PM | Psyence Biomedical (1985062) Filer | Form 424B3 | |
| 11/20/2025 3:01 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/12/2025 7:00 AM | Psyence Biomedical (1985062) Filer | Form 424B3 | |
| 11/10/2025 3:14 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/03/2025 7:34 AM | Psyence Biomedical (1985062) Filer | Form 424B3 | |
| 10/14/2025 3:06 PM | Psyence Biomedical (1985062) Filer | Form F-1/A | |
| 10/06/2025 4:30 PM | Psyence Biomedical (1985062) Filer | Form F-1/A | |
| 08/06/2025 7:29 AM | Psyence Biomedical (1985062) Filer | Form F-3 Registration statement for securities of certain foreign private issuers | |
| 07/23/2025 4:27 PM | Psyence Biomedical (1985062) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 06/25/2025 4:16 PM | Psyence Biomedical (1985062) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 06/25/2025 3:01 PM | Psyence Biomedical (1985062) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |